# Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

> **NCT00539773** · NA · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 10 (actual)

## Conditions studied

- Transitional Carcinoma of Urinary Bladder

## Interventions

- **DRUG:** BCG, Interferon

## Key facts

- **NCT ID:** NCT00539773
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539773, "Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00539773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*